Basilea Pharmaceutica
BSLN.SW
#5988
Rank
C$1.53 B
Marketcap
C$124.20
Share price
0.14%
Change (1 day)
49.30%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2025: C$5.96

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is C$5.96. In 2025 the company made an earnings per share (EPS) of C$5.96 a decrease over its 2024 EPS that were of C$10.19.

EPS history for Basilea Pharmaceutica from 2002 to 2025

Annual EPS

Year EPS Change
2025C$5.96-41.53%
2024C$10.19586.89%
2023C$1.48-6.28%
2022C$1.58-273.94%
2021C-$0.91-60.87%
2020C-$2.32-24.46%
2019C-$3.08-26.92%
2018C-$4.2159.83%
2017C-$2.63-63.06%
2016C-$7.13-19.26%
2015C-$8.8346.12%
2014C-$6.0510.07%
2013C-$5.49-36.76%
2012C-$8.68-5.42%
2011C-$9.18-153.36%
2010C$17.21-198.47%
2009C-$17.48-15.34%
2008C-$20.6416.7%
2007C-$17.6936.07%
2006C-$13.0079.07%
2005C-$7.26-46.79%
2004C-$13.649.83%
2003C-$12.42-38.94%
2002C-$20.34